An autosomal recessive nonsyndromic deafness that has material basis in variation in the chromosome region 18p11.32-p11.31.
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation surrounding autosomal recessive nonsyndromic hearing loss 46 is limited due to its rarity and the recent identification of its genetic basis. As fewer individuals are affected, systematic clinical studies have been challenging to conduct. This can lead to gaps in knowledge about the condition, but ongoing research may provide more insights in the future.
The primary clinical feature of autosomal recessive nonsyndromic hearing loss 46 is profound sensorineural hearing impairment, which affects individuals from infancy. This type of hearing loss is not associated with other syndromic features, making it nonsyndromic. Early identification and intervention are crucial for managing the impact of hearing loss on communication and development.
To navigate your care effectively, consider consulting an audiologist or an otolaryngologist (ENT) with experience in hereditary hearing loss. They can provide tailored management strategies and support. Additionally, genetic counseling may be beneficial, especially for family planning and understanding inheritance patterns. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Participating in clinical trials may also provide access to cutting-edge treatments and contribute to research efforts.
Currently, there are two active clinical trials focused on autosomal recessive nonsyndromic hearing loss 46. These trials may explore various aspects of the condition, including potential interventions and management strategies. You can find more information about these trials at ClinicalTrials.gov by searching for 'autosomal recessive nonsyndromic hearing loss 46'.
Actionable guidance for navigating care for autosomal recessive nonsyndromic hearing loss 46
To navigate your care effectively, consider consulting an audiologist or an otolaryngologist (ENT) with experience in hereditary hearing loss. They can provide tailored management strategies and support. Additionally, genetic counseling may be beneficial, especially for family planning and understanding inheritance patterns. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Participating in clinical trials may also provide access to cutting-edge treatments and contribute to research efforts.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation surrounding autosomal recessive nonsyndromic hearing loss 46 is limited due to its rarity and the recent identification of its genetic basis. As fewer individuals are affected, systematic clinical studies have been challenging to conduct. This can lead to gaps in knowledge about the condition, but ongoing research may provide more insights in the future.
The primary clinical feature of autosomal recessive nonsyndromic hearing loss 46 is profound sensorineural hearing impairment, which affects individuals from infancy. This type of hearing loss is not associated with other syndromic features, making it nonsyndromic. Early identification and intervention are crucial for managing the impact of hearing loss on communication and development.
To navigate your care effectively, consider consulting an audiologist or an otolaryngologist (ENT) with experience in hereditary hearing loss. They can provide tailored management strategies and support. Additionally, genetic counseling may be beneficial, especially for family planning and understanding inheritance patterns. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Participating in clinical trials may also provide access to cutting-edge treatments and contribute to research efforts.
Currently, there are two active clinical trials focused on autosomal recessive nonsyndromic hearing loss 46. These trials may explore various aspects of the condition, including potential interventions and management strategies. You can find more information about these trials at ClinicalTrials.gov by searching for 'autosomal recessive nonsyndromic hearing loss 46'.
Actionable guidance for navigating care for autosomal recessive nonsyndromic hearing loss 46
To navigate your care effectively, consider consulting an audiologist or an otolaryngologist (ENT) with experience in hereditary hearing loss. They can provide tailored management strategies and support. Additionally, genetic counseling may be beneficial, especially for family planning and understanding inheritance patterns. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Participating in clinical trials may also provide access to cutting-edge treatments and contribute to research efforts.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation surrounding autosomal recessive nonsyndromic hearing loss 46 is limited due to its rarity and the recent identification of its genetic basis. As fewer individuals are affected, systematic clinical studies have been challenging to conduct. This can lead to gaps in knowledge about the condition, but ongoing research may provide more insights in the future.
The primary clinical feature of autosomal recessive nonsyndromic hearing loss 46 is profound sensorineural hearing impairment, which affects individuals from infancy. This type of hearing loss is not associated with other syndromic features, making it nonsyndromic. Early identification and intervention are crucial for managing the impact of hearing loss on communication and development.
To navigate your care effectively, consider consulting an audiologist or an otolaryngologist (ENT) with experience in hereditary hearing loss. They can provide tailored management strategies and support. Additionally, genetic counseling may be beneficial, especially for family planning and understanding inheritance patterns. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Participating in clinical trials may also provide access to cutting-edge treatments and contribute to research efforts.
Currently, there are two active clinical trials focused on autosomal recessive nonsyndromic hearing loss 46. These trials may explore various aspects of the condition, including potential interventions and management strategies. You can find more information about these trials at ClinicalTrials.gov by searching for 'autosomal recessive nonsyndromic hearing loss 46'.
Actionable guidance for navigating care for autosomal recessive nonsyndromic hearing loss 46
To navigate your care effectively, consider consulting an audiologist or an otolaryngologist (ENT) with experience in hereditary hearing loss. They can provide tailored management strategies and support. Additionally, genetic counseling may be beneficial, especially for family planning and understanding inheritance patterns. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Participating in clinical trials may also provide access to cutting-edge treatments and contribute to research efforts.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Age of onset indicates when symptoms typically first appear.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.